This project will rely on mouse genetic tools in order to dissect, at the molecular level, the role of specific genes in determining differences in emotionality. We plan to manipulate the levels of expression of the two corticosteroid receptor genes the glucocorticoid receptor, GR, and the mineralocorticoid receptor, MR to create animals that either over- or under-express them. We plan to use a promoter that exhibits region- specific differences in activity to obtain altered gene expression in a region-specific manner within the brain. The targeted regions include structures that typically express these genes and regulate reactivity to stress and anxiety, including the hippocampus and the cortex. Finally, we plan to use inducible constructs in order to gain control over the timing and duration of over- or under-expression of these receptors, and to do so in a brain regions-specific manner. In these animal models, we will ascertain the behavioral and neuroendocrine profiles of the mice, and examine the consequences of the genetic manipulation on learning and memory. We will also study the effect of a chronic social stress (social defeat) on both behavior and gene expression in the brain. We will determine whether this single manipulation leads to patterns of gene expression in specific brain circuits that resemble what we observe in the context of spontaneous differences in emotionality in the rat. This would begin to point to certain genes, such as the corticosteroid receptors, as key triggers or """"""""switches"""""""" in the modulation of emotional reactivity. These studies should not only yield novel animal models with altered emotional reactivity, they should also shed light on the mechanisms that might control spontaneous differences in emotionality as studied in the other projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
2P01MH042251-16
Application #
6589937
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2002-04-16
Project End
2006-11-30
Budget Start
Budget End
Support Year
16
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hillhouse, Todd M; Porter, Joseph H (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1-21
Meyers, K K; Crane, N A; O'Day, R et al. (2015) Smoking history, and not depression, is related to deficits in detection of happy and sad faces. Addict Behav 41:210-7
Lohoff, F W; Hodge, R; Narasimhan, S et al. (2014) Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry 19:129-39
Tomita, Hiroaki; Ziegler, Mary E; Kim, Helen B et al. (2013) G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 4:297
Votruba, Kristen L; Langenecker, Scott A (2013) Factor structure, construct validity, and age- and education-based normative data for the Parametric Go/No-Go Test. J Clin Exp Neuropsychol 35:132-46
Vederman, Aaron C; Weisenbach, Sara L; Rapport, Lisa J et al. (2012) Modality-specific alterations in the perception of emotional stimuli in Bipolar Disorder compared to Healthy Controls and Major Depressive Disorder. Cortex 48:1027-34
Turner, Cortney A; Watson, Stanley J; Akil, Huda (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76:160-74
Turner, Cortney A; Clinton, Sarah M; Thompson, Robert C et al. (2011) Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc Natl Acad Sci U S A 108:8021-5
Mickey, Brian J; Zhou, Zhifeng; Heitzeg, Mary M et al. (2011) Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 68:158-66

Showing the most recent 10 out of 75 publications